Noriyuki Tatemichi

Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.

Toshimitsu Niwa, Tomoyuki Katsuzaki, Shigeru Miyazaki et al. · Journal of Clinical Investigation · 1997 · 192 citations · Full text

Medicine, Biochemistry, Endocrinology +14

Modification of β2m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum

Toshimitsu Niwa, Tomoyuki Katsuzaki, Tomoko Momoi et al. · Kidney International · 1996 · 80 citations · Full text

Medicine, Biochemistry, Nephrology +12

Amyloid β2-microglobulin is modified with Nε-(carboxymethyl)lysine in dialysis-related amyloidosis

Toshimitsu Niwa, Mitsuhiko Sato, Tomoyuki Katsuzaki et al. · Kidney International · 1996 · 66 citations

Life Sciences, Biochemistry, Nephrology +11

Amyloid β2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

Toshimitsu Niwa, Tomoyuki Katsuzaki, Shigeru Miyazaki et al. · Kidney International · 1997 · 61 citations

Life Sciences, Biochemistry, Nephrology +15

Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin‐induced diabetes

Toshimitsu Niwa, Tomoyuki Katsuzaki, Yayoi Ishizaki et al. · FEBS Letters · 1997 · 55 citations · Full text

Medicine, Biochemistry, Pharmacology +11